Maze Therapeutics, Inc. 13F holders
161 funds reported a position in Maze Therapeutics, Inc. in their 13F for the quarter ended 30 June 2026, together 58.5 million shares worth $1.75 billion. Against the quarter before, 36 opened a position, 66 added, 36 trimmed and 39 sold out; together they bought a net 6.3 million shares. The largest holders: Frazier Life Sciences Management, L.P., TRV GP IV, LLC and ARCH Venture Management, LLC.
Funds holding161-4 on Q1 2026
Shares they held58.5Mworth $1.75 billion
Net bought on the quarter6.3M sharesabout $188.3 million at the funds' values
Funds buying to selling102 to 75opened or added, to cut or sold
Opened 36Added 66Held 21Trimmed 36Sold out 39
What each fund did in MAZE against its 13F for the quarter before; a change under 0.1% of a holding counts as held
Funds reporting a position in MAZE in their 13F, each quarter; hover a bar for the shares they held
Filed so far for the quarter to 30 September 2026
2,671 funds have filed their 13F for the quarter so far; the rest are due by 16 November 2026. Of those, 12 reported a position in Maze Therapeutics, Inc.: 2 opened one, 5 added, 2 trimmed and 1 sold out, a net 44,178 shares bought.
| Fund | Change in shares | Shares now | Status | Filing |
|---|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | +42,755 | 57,125 | added | 13F |
| Sterling Capital Management LLC | +867 | 1,089 | added | 13F |
| GF Fund Management Co. Ltd | +349 | 1,370 | added | 13F |
| Versant Capital Management, Inc | +202 | 202 | new | 13F |
| IFP Advisors, Inc | -67 | 261 | trimmed | 13F |
| Nisa Investment Advisors, LLC | +47 | 326 | added | 13F |
| Financial Consulate, Inc. | +42 | 42 | new | 13F |
| Gamma Investing LLC | -12 | 158 | trimmed | 13F |
| Farther Finance Advisors, LLC | +1 | 327 | added | 13F |
| SBI Securities Co., Ltd. | -6 | 0 | sold out | 13F |
The largest moves in the name among the funds that have filed, against each fund's previous 13F.
The well-known funds
Of the 44 funds followed here, 5 reported a position in Maze Therapeutics, Inc. in a 13F for the quarter ended 30 June 2026. The largest: FMR LLC, 1.1 million shares worth $31.5 million, 0.0% of its reported book. Sold out: Renaissance Technologies, Millennium Management. In the quarter, 4 funds added or opened a position and 2 trimmed or sold out; together they bought a net 659,209 shares, about $19.7 million at the funds' own value per share on 30 June 2026. A change under 0.1% of a holding counts as held.
| Fund | Shares | Value | Of its book | Change on the quarter | Status | Quarter ended | Filing |
|---|---|---|---|---|---|---|---|
| FMR LLC | 1,056,959 | $31.5 million | 0.0% | +192,745 | added | 30 June 2026 | 13F |
| Geode Capital Management | 858,054 | $25.6 million | 0.0% | +258,087 | added | 30 June 2026 | 13F |
| Citadel Advisors | 852,676 | $25.4 million | 0.0% | +76,962 | added | 30 June 2026 | 13F |
| Two Sigma Investments | 192,952 | $5.8 million | 0.0% | +177,107 | added | 30 June 2026 | 13F |
| Alyeska | 100,000 | $3.0 million | 0.0% | no change | held | 30 June 2026 | 13F |
| Renaissance Technologies | 0 | $0 | 0.0% | -15,800 | exited | 30 June 2026 | 13F |
| Millennium Management | 0 | $0 | 0.0% | -29,892 | exited | 30 June 2026 | 13F |
Value is what the fund reported.
Read more
Change is shares against the fund's previous 13F; a fund with one filing read shows no change. 13Fs cover long US positions of managers above $100 million and are filed up to 45 days after the quarter.The largest holders
| Fund | Shares | Share of all | Value | Of its book | Change in shares | Filing |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 5,032,915 | 8.60% | $150.2 million | 3.27% | +465,641 | 13F |
| TRV GP IV, LLC | 4,473,958 | 7.64% | $133.5 million | 52.63% | no change | 13F |
| ARCH Venture Management, LLC | 4,120,053 | 7.04% | $123.0 million | 11.18% | no change | 13F |
| Deep Track Capital, LP | 3,732,569 | 6.38% | $111.4 million | 1.64% | +255,007 | 13F |
| BlackRock, Inc. | 3,502,841 | 5.98% | $104.5 million | 0.00% | +932,416 | 13F |
| Jupiter Topco LLC | 3,408,045 | 5.82% | $101.8 million | 0.04% | first 13F | 13F |
| T. Rowe Price Investment Management, Inc. | 2,603,682 | 4.45% | $77.7 million | 0.05% | new | 13F |
| Logos Global Management LP | 1,935,000 | 3.31% | $57.7 million | 2.49% | +700,000 | 13F |
| Vanguard Capital Management LLC | 1,778,222 | 3.04% | $53.1 million | 0.00% | +342,566 | 13F |
| a16z Capital Management, L.L.C. | 1,702,225 | 2.91% | $50.8 million | 0.36% | no change | 13F |
| Venrock Adviser, LLC | 1,602,034 | 2.74% | $47.8 million | 1.45% | no change | 13F |
| Alphabet Inc. | 1,388,583 | 2.37% | $41.4 million | 0.04% | no change | 13F |
| Braidwell LP | 1,140,040 | 1.95% | $34.0 million | 1.31% | new | 13F |
| Farallon Capital Management, L.l.c. | 1,107,814 | 1.89% | $33.1 million | 0.20% | +734,814 | 13F |
| FMR LLC | 1,056,959 | 1.81% | $31.5 million | 0.00% | +192,745 | 13F |
| General Catalyst Group Management, LLC | 1,035,910 | 1.77% | $30.9 million | 16.40% | no change | 13F |
| State Street Corp. | 997,533 | 1.70% | $29.8 million | 0.00% | +360,811 | 13F |
| Driehaus Capital Management LLC | 954,886 | 1.63% | $28.5 million | 0.17% | +318,724 | 13F |
| TRV GP V, LLC | 950,800 | 1.62% | $28.4 million | 5.69% | no change | 13F |
| JPMorgan Chase & Co. | 964,011 | 1.65% | $28.0 million | 0.00% | +905,565 | 13F |
| Marshall Wace, LLP | 914,572 | 1.56% | $27.3 million | 0.02% | +603,933 | 13F |
| Geode Capital Management, LLC | 858,054 | 1.47% | $25.6 million | 0.00% | +258,087 | 13F |
| Citadel Advisors LLC | 852,676 | 1.46% | $25.4 million | 0.01% | +76,962 | 13F |
| Casdin Capital, LLC | 843,857 | 1.44% | $25.2 million | 1.26% | +85,000 | 13F |
| ArrowMark Colorado Holdings LLC | 767,383 | 1.31% | $22.9 million | 0.95% | no change | 13F |
| Woodline Partners LP | 736,216 | 1.26% | $22.0 million | 0.07% | +85,987 | 13F |
| Bessemer Group Inc. | 481,790 | 0.82% | $14.4 million | 0.02% | no change | 13F |
| Sphera Funds Management Ltd | 417,564 | 0.71% | $12.5 million | 1.78% | +190,221 | 13F |
| Vanguard Portfolio Management LLC | 393,107 | 0.67% | $11.7 million | 0.00% | +197,565 | 13F |
| Aberdeen Group plc | 383,773 | 0.66% | $11.5 million | 0.02% | +157,546 | 13F |
| Ikarian Capital, LLC | 378,999 | 0.65% | $11.3 million | 1.85% | no change | 13F |
| Hhlr Advisors, Ltd | 366,028 | 0.63% | $10.9 million | 1.31% | no change | 13F |
| ADAR1 Capital Management, LLC | 339,276 | 0.58% | $10.1 million | 0.48% | +289,181 | 13F |
| Squadron Capital Management LLC | 335,000 | 0.57% | $10.0 million | 3.42% | +77,500 | 13F |
| Bank of America Corp. | 321,227 | 0.55% | $9.6 million | 0.00% | +126,143 | 13F |
| Northern Trust Corp. | 294,742 | 0.50% | $8.8 million | 0.00% | +83,360 | 13F |
| Goldman Sachs Group Inc. | 293,144 | 0.50% | $8.7 million | 0.00% | +13,431 | 13F |
| Candriam S.C.A. | 273,932 | 0.47% | $8.2 million | 0.04% | -4,235 | 13F |
| Hudson Bay Capital Management LP | 270,000 | 0.46% | $8.1 million | 0.04% | +261,850 | 13F |
| Charles Schwab Investment Management Inc. | 260,566 | 0.45% | $7.8 million | 0.00% | +74,133 | 13F |
| Adage Capital Partners GP, L.l.c. | 248,000 | 0.42% | $7.4 million | 0.01% | -930,000 | 13F |
| Mass General Brigham, Inc | 239,994 | 0.41% | $7.2 million | 1.98% | no change | 13F |
| Ameriprise Financial Inc. | 227,425 | 0.39% | $6.8 million | 0.00% | +119,939 | 13F |
| Vanguard Fiduciary Trust Co. | 219,938 | 0.38% | $6.6 million | 0.00% | +68,938 | 13F |
| RTW Investments, LP | 212,000 | 0.36% | $6.3 million | 0.05% | new | 13F |
| Schroder Investment Management Group | 199,872 | 0.34% | $5.8 million | 0.00% | +162,691 | 13F |
| Two Sigma Investments, LP | 192,952 | 0.33% | $5.8 million | 0.00% | +177,107 | 13F |
| Boothbay Fund Management, LLC | 188,857 | 0.32% | $5.6 million | 0.10% | -95,619 | 13F |
| ExodusPoint Capital Management, LP | 183,264 | 0.31% | $5.5 million | 0.05% | new | 13F |
| SummitTX Capital, L.P. | 176,291 | 0.30% | $5.3 million | 0.14% | +92,541 | 13F |
The 50 largest of the 161 funds that reported a position in MAZE in their 13F for the quarter ended 30 June 2026, by the value each reported.
Read more
Share of all is the fund's part of all the shares the funds reported. Change is shares against the fund's 13F for the quarter before. A 13F lists a manager's long positions in US-listed shares at the quarter's end. What is a 13F?Options the funds reported on MAZE
| Fund | Option | Shares under the options | Value of those shares | Quarter ended | Filing |
|---|---|---|---|---|---|
| Citadel Advisors | Calls | 12,600 | $375,984 | 30 June 2026 | 13F |
| Citadel Advisors | Puts | 9,600 | $286,464 | 30 June 2026 | 13F |
A 13F lists calls and puts by the shares they cover and what those shares were worth at the quarter's end, not what the options cost.
Read more
They are not counted in the holdings above. A put gains when the stock falls, a call when it rises, and a fund may hold either to hedge.Schedule 13D and 13G filed on the name, last twelve months
| Filed | Schedule | Who | Holding | Of the class | Event date | Rule or purpose | Filing |
|---|---|---|---|---|---|---|---|
| 14 August 2026 | 13G/A | Paradigm BioCapital Advisors LP and 7 others | 0 | 0.0% | 30 June 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 29 July 2026 | 13G | BlackRock, Inc. and 1 other | 3.0 million | 5.4% | 30 June 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 15 May 2026 | 13G/A | Janus Henderson Group PLC and 1 other | 2.9 million | 5.8% | 31 March 2026 | passive, institutional (13d-1(b)) | EDGAR |
| 1 April 2026 | 13G | Paradigm BioCapital Advisors LP and 7 others | 3.1 million | 6.1% | 25 March 2026 | passive, under 20% (13d-1(c)) | EDGAR |
| 13 February 2026 | 13G/A | Frazier Life Sciences Public Fund, L.P. and 27 others | 4.3 million | 9.0% | 31 December 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 13 February 2026 | 13G/A | Third Rock Ventures IV, L.P. and 11 others | 4.5 million | 9.3% | 31 December 2025 | passive, other (13d-1(d)) | EDGAR |
| 6 February 2026 | 13G/A | GV 2019, L.P. and 17 others | 1.4 million | 2.9% | 31 December 2025 | passive, other (13d-1(d)) | EDGAR |
| 14 November 2025 | 13G/A | Janus Henderson Group PLC and 1 other | 3.2 million | 7.3% | 30 September 2025 | passive, institutional (13d-1(b)) | EDGAR |
| 14 November 2025 | 13G/A | Foresite Capital Fund IV, L.P. and 9 others | 608,948 | 1.4% | 30 September 2025 | passive, under 20% (13d-1(c)) | EDGAR |
| 13 November 2025 | 13G/A | Matrix Capital Management Company, LP and 3 others | 1.7 million | 3.5% | 30 September 2025 | passive, other (13d-1(d)) | EDGAR |
A Schedule 13D is filed by anyone who crosses 5% of a class with intent to influence; a 13G by a passive holder.
Read more
Amendments (/A) report a change, including an exit to zero. Holding and percentage are as the filer stated them on the cover page; the purpose is the filer's own words, cut short. 13D and 13GFails to deliver
| Settlement date | Shares failed | Price | File |
|---|---|---|---|
| 16 September 2026 | 6,859 | $24.23 | SEC |
| 2 September 2026 | 1,030 | $26.53 | SEC |
| 1 September 2026 | 2,250 | $26.57 | SEC |
| 28 August 2026 | 4,156 | $28.60 | SEC |
| 27 August 2026 | 270 | $29.58 | SEC |
| 25 August 2026 | 5,696 | $29.60 | SEC |
| 21 August 2026 | 5,794 | $28.93 | SEC |
Shares that failed to deliver at settlement, per day, from the SEC's half-month files, which arrive about two weeks after the period.